Tonghua Dongbao Pharmaceutical Co., Ltd.

SSE:600867.SS

8.11 (CNY) • At close June 10, 2025
Bedrijfsnaam Tonghua Dongbao Pharmaceutical Co., Ltd.
Symbool 600867.SS
Munteenheid CNY
Prijs 8.09
Beurswaarde 15,534,991,888
Dividendpercentage 2.49%
52-weken bereik 7 - 9.64
Industrie Drug Manufacturers—General
Sector Healthcare
CEO Mr. Sheng Leng Chun
Website https://www.thdb.com

An error occurred while fetching data.

Over Tonghua Dongbao Pharmaceutical Co., Ltd.

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro;

Vergelijkbare Aandelen

Liaoning Cheng Da Co., Ltd. logo

Liaoning Cheng Da Co., Ltd.

600739.SS

10.79 CNY

Zhejiang Orient Gene Biotech Co., Ltd. logo

Zhejiang Orient Gene Biotech Co., Ltd.

688298.SS

26.97 CNY

Eyebright Medical Technology (Beijing) Co., Ltd. logo

Eyebright Medical Technology (Beijing) Co., Ltd.

688050.SS

73.4 CNY

China National Medicines Corporation Ltd. logo

China National Medicines Corporation Ltd.

600511.SS

31.11 CNY

Hubei Jumpcan Pharmaceutical Co., Ltd. logo

Hubei Jumpcan Pharmaceutical Co., Ltd.

600566.SS

27.63 CNY

Sansure Biotech Inc. logo

Sansure Biotech Inc.

688289.SS

19.97 CNY

Elion Energy Company Limited logo

Elion Energy Company Limited

600277.SS

0.38 CNY

Joincare Pharmaceutical Group Industry Co.,Ltd. logo

Joincare Pharmaceutical Group Industry Co.,Ltd.

600380.SS

11.94 CNY

Sinocelltech Group Limited logo

Sinocelltech Group Limited

688520.SS

46.99 CNY

Zhejiang Ausun Pharmaceutical Co., Ltd. logo

Zhejiang Ausun Pharmaceutical Co., Ltd.

603229.SS

9.4 CNY

Financiële Gegevens

Cijfers zijn in miljoenen (CNY)

Cijfers zijn in miljoenen (CNY)